As highly accurate blood tests for Alzheimer’s disease are moving closer to use in physician’s offices, new research suggests that they may revolutionize the accuracy of diagnosis and provide a cleaner, quicker path to research participation and treatment, according to data reported today at the Alzheimer’s Association International Conference® (AAIC®) 2024, in Philadelphia and online.
Blood tests that accurately and reliably detect Alzheimer’s hallmark brain changes signal a shift to simpler, more accurate and earlier detection and diagnosis, potentially superseding current methods that are expensive, invasive and not always accessible.
A blood test was around 90% accurate in identifying Alzheimer’s disease in patients with cognitive symptoms seen in primary care and at specialized memory care clinics. In the research study, primary care physicians were 63% accurate and specialists were 73% accurate when not using the blood test.
Blood tests, once they are confirmed, could enhance recruitment for Alzheimer’s clinical trials and slash wait times for Alzheimer’s disease assessment.
PHILADELPHIA, July 28, 2024 /PRNewswire/ — As highly accurate blood tests for Alzheimer’s disease are moving closer to use in physician’s offices, new research suggests that they may revolutionize the accuracy of diagnosis and provide a cleaner, quicker path to research participation and treatment, according to data reported today at the Alzheimer’s Association International Conference® (AAIC®) 2024, in Philadelphia and online.
Dementia is often underdiagnosed—and if it is diagnosed by a clinician, many people nonetheless are unaware or uninformed of their diagnosis, according to the 2024 Alzheimer’s Disease Facts and Figures report. Blood tests for Alzheimer’s are demonstrating in research that they could significantly improve a clinician’s accuracy and confidence, provide greater accessibility and a platform for enhanced communication.
